Works matching IS 03065251 AND DT 2001 AND VI 51 AND IP 5
1
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 506P
- Cleophas, T.J.;
- Van Marum, R.
- Article
2
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 505P
- Van Der Kuy, P.-H. M.;
- Merkus, F.W.H.M.;
- Russell, F.G.M.;
- Lohman, J.J.H.M.;
- Hooymans, P.M.
- Article
3
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 504P
- Verschraagen, M.;
- Boven, E.;
- Ruijter, R.;
- Westerman, M.;
- Hausheer, F.H.;
- Van Der Vijgh, W.J.F.
- Article
4
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 499P
- Mulder, W.M.C.;
- de Klerk, S.;
- Settels, J.J.;
- Wesseling, K.H.;
- Van Boxtel, C.J.
- Article
5
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 503P
- Van Der Wild, J.J.;
- Neef, C.
- Article
6
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 503P
- Derijks, L.J.J.;
- Engels, L.G.J.B.;
- Hooymans, P.M.;
- Lohman, J.J.H.M.
- Article
7
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 501P
- Wiersma, H.E.;
- Benninga, M.;
- Butter, J.J.;
- Omari, T.;
- Van Boxtel, C.J.
- Article
8
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 501P
- de Hoon, J.N.J.M.;
- Troost, J.;
- Van Bortel, L.M.A.B.;
- Struijker-Boudier, H.A.J.
- Article
9
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 500P
- Van Baak, M.A.;
- Hul, G.;
- Toubro, S.;
- Astrup, A.;
- Gottestdiener, K.M.;
- Desmet, M.;
- Saris, W.H.M.
- Article
10
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 502P
- Van Rossum, L.K.;
- Cransberg, K.;
- Derkx, F.;
- Lindemans, J.;
- de Rijke, Y.B.;
- Zietse, R.;
- Vulto, A.G.
- Article
11
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 499P
- Van Kraaij, D.J.W.;
- Vollaard, E.J.;
- de Metz, M.;
- Witterland, A.
- Article
12
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 498P
- Knibbe, C.A.J.;
- Zuideveld, K.P.;
- Dejongh, J.;
- Kuks, P.F.M.;
- Aarts, L.P.H.J.;
- Danhof, M.
- Article
13
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 497P
- Veldkamp, A.I.;
- Van Heeswijk, R.P.G.;
- Mulder, J.W.;
- Meenhorst, P.L.;
- Schreij, G.;
- Van Der Geest, S.;
- Beijnen, J.H.;
- Lange, J.M.A.;
- Hoetelmans, R.M.W.
- Article
14
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 497P
- de Maat, M.M.R.;
- Frankfort, S.V.;
- Mathot, R.A.A.;
- Mulder, J.W.;
- Meenhorst, P.L.;
- Van Gorp, E.C.M.;
- Neijnen, J.H.;
- de Boer, A.;
- Hoetelmans, R.M.W.
- Article
15
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 496P
- Teeuwisse, A.K.;
- Lindemans, A.D.;
- Verschuren, W.M.M.;
- Klungel, O.H.;
- Porsius, A.J.;
- de Boer, A.
- Article
16
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 496P
- Schillevoort, I.;
- Van Puijenbroek, E.P.;
- de Boer, A.;
- Roos, R.A.C.;
- Jansen, P.A.F.;
- Leufkens, H.G.M.
- Article
17
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 495P
- Van De Vijver, D.A.M.C.;
- Roos, R.A.C.;
- Jansen, P.A.F.;
- Porsius, A.J.;
- de Boer, A.
- Article
18
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 494P
- Edelbroek, P.M.;
- Vermeij, T.A.C.;
- Brekelmans, G.J.F.;
- Debets, R.M. Chr.;
- Geesink, H.H.;
- Rademaker, M.V.
- Article
19
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 492P
- Van Den Berg, E.J.;
- Van Der Wilt, G.J.;
- Meulendijks, C.F.M.;
- Droogleever-Fortuyn, H.;
- Verkes, R.J.;
- Kramers, C.
- Article
20
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 493P
- Cleophas, T.J.;
- Van Ouwerkerk, B.M.;
- Van Der Meulen, J.;
- Zwinderman, A.H.;
- Van Marum, R.
- Article
23
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 489, doi. 10.1046/j.1365-2125.2001.01364.x
- Fourrier, Annie;
- Bégaud, Bernard;
- Alpérovitch, Annick;
- Verdier-Taillefer, Marie-Hélène;
- Touzé, Emmanuel;
- Decker, Nicole;
- Imbs, Jean-Louis
- Article
24
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 482, doi. 10.1046/j.1365-2125.2001.01363.x
- Guazzi, Marco;
- Brambilla, Roberto;
- Agostoni, Piergiuseppe;
- Guazzi, Maurizio D.
- Article
25
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 478, doi. 10.1046/j.1365-2125.2001.01327.x
- Begg, E. J.;
- Robson, R. A.;
- Gardiner, S. J.;
- Hudson, L. J.;
- Reece, P. A.;
- Olson, S. C.;
- Posvar, E. L.;
- Sedman, A. J.
- Article
26
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 475, doi. 10.1046/j.1365-2125.2001.01371.x
- Article
27
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 471, doi. 10.1046/j.1365-2125.2001.01331.x
- Tamminga, Wim J.;
- Wemer, Johan;
- Oosterhuis, Berend;
- Wieling, Jaap;
- Touw, Daan J.;
- de Zeeuw, Rokus A.;
- de Leij, Lou F.M.H.;
- Jonkman, H.G.
- Article
28
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 461, doi. 10.1046/j.1365-2125.2001.01386.x
- Yeo, Karen Rowland;
- Yeo, Wilfred W.
- Article
29
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 451, doi. 10.1046/j.1365-2125.2001.01370.x
- Johnson, Trevor N.;
- Tanner, M. Stuart;
- Taylor, Christopher J.;
- Tucker, Geoffrey T.
- Article
30
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 443, doi. 10.1046/j.1365-2125.2001.01372.x
- Lebrun-Vignes, B.;
- Archer, V. Corbrion;
- Diquet, B.;
- Levron, J. C.;
- Chosidow, O.;
- Puech;
- Warot, D.
- Article
31
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 437, doi. 10.1046/j.1365-2125.2001.01367.x
- Fleishaker, Joseph C.;
- Ryan, Kristi K.;
- Jansat, Josep M.;
- Carel, Barbara J.;
- Bell, David J.A.;
- Burke, Moira T.;
- Azie, Nkechi E.
- Article
32
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 429, doi. 10.1046/j.1365-2125.2001.01358.x
- Yates, R. A.;
- Wong, J.;
- Seiberling, M.;
- Merz, M.;
- März, W.;
- Nauck, M.
- Article
33
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 423, doi. 10.1046/j.1365-2125.2001.01387.x
- de Visser, S. J.;
- van Gerven, J. M. A.;
- Schoemaker, R. C.;
- Cohen, A. F.
- Article
34
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 415, doi. 10.1046/j.1365-2125.2001.01373.x
- Luippold, Gerd;
- Schneider, Swetlana;
- Stefanescu, Andreea;
- Benöhr, Peter;
- Mühlbauer, Bernd
- Article
35
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 410, doi. 10.1046/j.1365-2125.2001.01389.x
- Marcellin, P.;
- de Bony, F.;
- Garret, C.;
- Altman, C.;
- Boige, V.;
- Castelnau, C.;
- Laurent-Puig, P.;
- Trinchet, J. C.;
- Rolan, P.;
- Chen, C.;
- Mamet, J. P.;
- Bidault, R.
- Article
36
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 400, doi. 10.1046/j.0306-5251.2001.01374.x
- Daley-Yates, Peter T.;
- Price, Alison C.;
- Sisson, Jonathan R.;
- Pereira, Adrian;
- Dallow, Nigel
- Article
37
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 394, doi. 10.1046/j.1365-2125.2001.01382.x
- Todd, Susan;
- Whitehead, Anne;
- Stallard, Nigel;
- Whitehead, John
- Article
38
- British Journal of Clinical Pharmacology, 2001, v. 51, n. 5, p. 393, doi. 10.1046/j.0306-5251.2001.01430.x
- Whitehead, John;
- Todd, Susan;
- Whitehead, Anne;
- Stallard, Nigel
- Article